BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 21690492)

  • 1. Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies.
    Zuily S; Regnault V; Selton-Suty C; Eschwège V; Bruntz JF; Bode-Dotto E; De Maistre E; Dotto P; Perret-Guillaume C; Lecompte T; Wahl D
    Circulation; 2011 Jul; 124(2):215-24. PubMed ID: 21690492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Domingues V; Chock EY; Dufrost V; Risse J; Seshan SV; Barbhaiya M; Sartelet H; Erkan D; Wahl D; Zuily S
    Autoimmun Rev; 2022 Oct; 21(10):103158. PubMed ID: 35907609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Loiseau P; Foret T; DeFilippis EM; Risse J; Etienne AD; Dufrost V; Moulinet T; Erkan D; Devilliers H; Wahl D; Zuily S
    Lupus; 2022 Nov; 31(13):1595-1605. PubMed ID: 36112747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.
    Perez-Villa F; Font J; Azqueta M; Espinosa G; Pare C; Cervera R; Reverter JC; Ingelmo M; Sanz G
    Arthritis Rheum; 2005 Jun; 53(3):460-7. PubMed ID: 15934103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Chock YP; Moulinet T; Dufrost V; Erkan D; Wahl D; Zuily S
    Autoimmun Rev; 2019 Nov; 18(11):102395. PubMed ID: 31520800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus.
    Farzaneh-Far A; Roman MJ; Lockshin MD; Devereux RB; Paget SA; Crow MK; Davis A; Sammaritano L; Levine DM; Salmon JE
    Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Echocardiographic abnormalities and antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Falcao CA; Alves IC; Chahade WH; Duarte AL; Lucena-Silva N
    Arq Bras Cardiol; 2002 Sep; 79(3):285-91. PubMed ID: 12386730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.
    Bernardoff I; Picq A; Loiseau P; Foret T; Dufrost V; Moulinet T; Unlu O; Erkan D; Wahl D; Zuily S
    Autoimmun Rev; 2022 Jan; 21(1):102913. PubMed ID: 34371159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies can identify lupus patients at risk of pulmonary hypertension: A systematic review and meta-analysis.
    Zuily S; Domingues V; Suty-Selton C; Eschwège V; Bertoletti L; Chaouat A; Chabot F; Regnault V; Horn EM; Erkan D; Wahl D
    Autoimmun Rev; 2017 Jun; 16(6):576-586. PubMed ID: 28411166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review.
    Mattos P; Santiago MB
    Clin Rheumatol; 2011 Feb; 30(2):165-71. PubMed ID: 21207090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
    Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
    Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution.
    Moyssakis I; Tektonidou MG; Vasilliou VA; Samarkos M; Votteas V; Moutsopoulos HM
    Am J Med; 2007 Jul; 120(7):636-42. PubMed ID: 17602939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Echocardiographic findings in asymptomatic systemic lupus erythematosus patients.
    Mohammed AG; Alghamdi AA; ALjahlan MA; Al-Homood IA
    Clin Rheumatol; 2017 Mar; 36(3):563-568. PubMed ID: 27866289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.
    Taraborelli M; Lazzaroni MG; Martinazzi N; Fredi M; Cavazzana I; Franceschini F; Tincani A
    Reumatismo; 2016 Dec; 68(3):137-143. PubMed ID: 27981815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transthoracic versus transesophageal echocardiography for detection of Libman-Sacks endocarditis: a randomized controlled study.
    Roldan CA; Qualls CR; Sopko KS; Sibbitt WL
    J Rheumatol; 2008 Feb; 35(2):224-9. PubMed ID: 18085739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus--a meta-analysis.
    Wahl DG; Guillemin F; de Maistre E; Perret C; Lecompte T; Thibaut G
    Lupus; 1997; 6(5):467-73. PubMed ID: 9229367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus.
    Plazak W; Gryga K; Milewski M; Podolec M; Kostkiewicz M; Podolec P; Musial J
    Lupus; 2011 Aug; 20(9):936-44. PubMed ID: 21636627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.